Table 3 Factors predicting willingness to quit daily snus use (daily snus users N = 784).

From: Factors predicting willingness to quit snus and cigarette use among young males

Variable

Univariate analysis

Multivariate analysis

N1 (%)

ORa

95% Cl

p value

ORb

95% Cl

p value

Age (in years)

 Mean 19.3, SD ± 0.7

733

1.07

0.90–1.27

0.468

   

Educational levela

Total

729

 

0.648

   

 Comprehensive school

71 (10%)

1

     

 Vocational school

309 (42%)

1.20

0.72–1.99

0.485

   

 Upper secondary education

349 (48%)

1.26

0.77–2.09

0.358

   

Dual use of snus and cigarettes

729

0.83

0.56–1.23

0.341

   

Duration of snus use (years)b

 Mean 3.24, SD ± 1.7

729

0.85

0.78–0.93

 < 0.001

0.91

0.83–1.00

0.059

Perceived harmfulness of use

 Total

721

  

 < 0.001

   

 Not at all

148 (21%)

1

  

1

  

 Neither harmless nor harmful

313 (43%)

1.80

1.19–2.72

0.005

1.72

1.09–2.72

0.021

 Clearly harmful

260 (36%)

3.19

2.09–4.86

 < 0.001

3.09

1.94–4.93

 < 0.001

Attempts to quit use

 Total

702

  

 < 0.001

   

 No attempts

379 (54%)

1

  

1

  

 One

165 (24%)

3.29

2.29–4.71

 < 0.001

2.67

1.81–3.94

 < 0.001

 Two or more

158 (23%)

4.17

2.88–6.05

 < 0.001

3.63

2.44–5.40

 < 0.001

Advice to quit snus use

 Total

670

1.54

1.07–2.21

0.019

1.25

0.90–1.99

0.145

Perceived addictiveness of snus

 Total

724

  

0.141

   

 Not at all

66 (9%

1

     

 Neither nor

193 (27%)

1.26

0.71–2.24

0.431

   

 Very addictive

465 (64%)

1.57

0.92–2.67

0.096

   

Level of dependence*

 Total

729

  

0.054

   

 No/low dependence

364 (50%)

1

     

 Moderate

162 (22%)

0.91

0.63–1.30

0.596

   

 Strong

122 (17%)

0.73

0.49–1.10

0.133

   

 Very strong

81 (11%)

0.53

0.32–0.87

0.013

   
  1. The relative order of the outcome values used in the regression: not willing to quit; willing to quit after 6 months; willing to quit within 6 months.
  2. ORa Univariate analysis: information missing for 51/784 cases.
  3. ORb Multivariate analysis: information missing for 105/628 cases.
  4. *Excluding the first cohort of two cohorts in 2014.